Adicet Bio receives FDA Fast Track designation for its systemic sclerosis treatment
Source: SeekingAlpha
2025-02-27 08:50:28 ET
More on Adicet Bio
- Seeking Alpha’s Quant Rating on Adicet Bio
- Historical earnings data for Adicet Bio
- Financial information for Adicet Bio
Read the full article on Seeking Alpha
For further details see:
Adicet Bio receives FDA Fast Track designation for its systemic sclerosis treatment
Adicet Bio Inc.
NASDAQ: ACET
ACET Trading
-1.94% G/L:
$7.07 Last:
45,129 Volume:
$7.41 Open:
ACET Latest News
ACET Stock Data
$70,641,246
7,595,730
46.88%
30
N/A
Biotechnology & Life Sciences
Healthcare
US
Boston
